Verification evidence is still being completed.
Adamant Health Oy
Kuopio, Finland
- Verified lead
- Paulus Carpelan
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Wearable Medical Devices, Surface EMG Analytics, and Parkinson's Disease Symptom Quantification
- Review cycle
- 24 April 2026
- Full address
- Hub Panostamo, KPY Novapolis, Microkatu 1, FI-70210 Kuopio, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Adamant Health About page naming Paulus Carpelan as CEO and Co-founder.
- Editorial note
- Kuopio digital-health medtech startup with named co-founder CEO, CE-marked wearable device, and a Gerresheimer partnership targeting Parkinson's disease.
Wearable Medical Devices, Surface EMG Analytics, and Parkinson's Disease Symptom Quantification
CE-marked medical device, ISO 13485 scope in development, Gerresheimer partnership
Kuopio digital-health medtech startup with named co-founder CEO, CE-marked wearable device, and a Gerresheimer partnership targeting Parkinson's disease.
Adamant Health Oy
Wearable Medical Devices, Surface EMG Analytics, and Parkinson's Disease Symptom Quantification · Medical-device and digital health delivery
Kuopio digital-health medtech startup with named co-founder CEO, CE-marked wearable device, and a Gerresheimer partnership targeting Parkinson's disease.
- Lead
- Paulus Carpelan (verified ↗)
- Address
- Hub Panostamo, KPY Novapolis, Microkatu 1, FI-70210 Kuopio, Finland (source ↗)
- Compliance
- CE-marked medical device · ISO 13485 scope in development
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Medical-device and digital health delivery
- Capabilities
- Wearable Sensor R&D · Surface EMG Analytics · Neurology Clinical Data Services
- Founded
- 2016
- Headcount
- 1-10
- Company page (open ↗)
Paulus Carpelan
Chief Executive Officer and Co-Founder
Medical-device and digital health delivery
Kuopio, Finland. Wearable Medical Devices, Surface EMG Analytics, and Parkinson's Disease Symptom Quantification. Review completed on 24 Apr 2026.
Fimea and EU MDR for medical-device oversight
CE-marked medical device, ISO 13485 scope in development, Gerresheimer partnership
Wearable Medical Devices, Surface EMG Analytics, and Parkinson's Disease Symptom Quantification
Kuopio digital-health medtech startup with named co-founder CEO, CE-marked wearable device, and a Gerresheimer partnership targeting Parkinson's disease.
Adamant Health is a University of Eastern Finland 2020 spin-off with a named co-founder CEO, a CE-marked wearable medical device, and a documented Gerresheimer partnership targeting Parkinson's disease.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Adamant Health Oy located?
- Adamant Health Oy operates from Hub Panostamo, KPY Novapolis, Microkatu 1, FI-70210 Kuopio, Finland, Kuopio, Finland.
- Who runs Adamant Health Oy?
- Adamant Health Oy is led by Paulus Carpelan, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What certifications does Adamant Health Oy hold?
- Adamant Health Oy is documented under CE-marked medical device, ISO 13485 scope in development.
- What does Adamant Health Oy do?
- Kuopio digital-health medtech startup with named co-founder CEO, CE-marked wearable device, and a Gerresheimer partnership targeting Parkinson's disease. Core capabilities: Wearable Sensor R&D, Surface EMG Analytics, Neurology Clinical Data Services.
Related technical briefs
Briefs that name Kuopio as a covered market or city.
